Target Price | $182.00 |
Price | $168.03 |
Potential | 8.31% |
Number of Estimates | 25 |
25 Analysts have issued a price target Procter & Gamble 2026 . The average Procter & Gamble target price is $182.00. This is 8.31% higher than the current stock price. The highest price target is $209.00 24.38% , the lowest is $157.00 6.56% . | |
A rating was issued by 31 analysts: 19 Analysts recommend Procter & Gamble to buy, 11 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2026 of 8.31% . Most analysts recommend the Procter & Gamble stock at Purchase. |
22 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $85.2b . This is 0.97% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $86.2b 2.19% , the lowest is $83.7b 0.81% .
This results in the following potential growth metrics:
2024 | $84.0b | 2.48% |
---|---|---|
2025 | $85.2b | 1.34% |
2026 | $88.0b | 3.29% |
2027 | $91.5b | 3.97% |
2028 | $95.3b | 4.17% |
19 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $23.9b . This is 5.73% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $24.3b 7.53% , the lowest is $23.0b 1.99% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $23.1b | 9.60% |
---|---|---|
2025 | $23.9b | 3.36% |
2026 | $25.4b | 6.37% |
2027 | $27.0b | 6.30% |
2028 | $28.0b | 3.75% |
2024 | 27.48% | 6.95% |
---|---|---|
2025 | 28.03% | 2.00% |
2026 | 28.86% | 2.96% |
2027 | 29.51% | 2.25% |
2028 | 29.39% | 0.41% |
11 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $15.9b . This is 7.74% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.4b 11.31% , the lowest is $15.3b 4.14% .
This results in the following potential growth metrics and future Net Margins:
2024 | $14.1b | 2.03% |
---|---|---|
2025 | $15.9b | 12.40% |
2026 | $17.3b | 9.04% |
2027 | $18.6b | 7.24% |
2028 | $19.7b | 6.34% |
2024 | 16.80% | 0.43% |
---|---|---|
2025 | 18.63% | 10.91% |
2026 | 19.67% | 5.58% |
2027 | 20.28% | 3.10% |
2028 | 20.71% | 2.12% |
11 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is $6.77 . This is 7.80% higher than earnings per share in the financial year 2024. The highest EPS forecast is $6.99 11.31% , the lowest is $6.54 4.14% .
This results in the following potential growth metrics and future valuations:
2024 | $6.02 | 2.03% |
---|---|---|
2025 | $6.77 | 12.46% |
2026 | $7.38 | 9.01% |
2027 | $7.91 | 7.18% |
2028 | $8.41 | 6.32% |
Current | 26.77 | 1.11% |
---|---|---|
2025 | 24.83 | 7.25% |
2026 | 22.77 | 8.30% |
2027 | 21.24 | 6.72% |
2028 | 19.97 | 5.98% |
Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an EV/Sales of 4.93 and an P/S ratio of 4.63 .
This results in the following potential growth metrics and future valuations:
Current | 4.97 | 2.47% |
---|---|---|
2025 | 4.93 | 0.89% |
2026 | 4.77 | 3.19% |
2027 | 4.59 | 3.82% |
2028 | 4.40 | 4.00% |
Current | 4.67 | 3.07% |
---|---|---|
2025 | 4.63 | 0.96% |
2026 | 4.48 | 3.19% |
2027 | 4.31 | 3.82% |
2028 | 4.14 | 4.00% |
Procter & Gamble...
Analyst | Rating | Action | Date |
---|---|---|---|
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 27 2025 |
Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Feb 24 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Jan 23 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jan 23 2025 |
DA Davidson |
Buy
➜
Buy
|
Unchanged | Jan 23 2025 |
Stifel |
Hold
➜
Hold
|
Unchanged | Jan 23 2025 |
RBC Capital |
Sector Perform
➜
Sector Perform
|
Unchanged | Jan 23 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Mar 27 2025 |
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Feb 24 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Jan 23 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jan 23 2025 |
Unchanged
DA Davidson:
Buy
➜
Buy
|
Jan 23 2025 |
Unchanged
Stifel:
Hold
➜
Hold
|
Jan 23 2025 |
Unchanged
RBC Capital:
Sector Perform
➜
Sector Perform
|
Jan 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.